ASTH vs FCN: stock comparison and AI forecast
Astrana Health, Inc. (ASTH) and Fti Consulting, Inc (FCN) compared on price performance, valuation, profitability and the daily AI forecast. · Alpha · vs market
Share
ASTH Astrana Health, Inc.
- Price
- $34.50 -4.4% · 6M
- Market Cap
- $1.92B
- P/E Ratio
- 48.6x
- Size
- small-cap
- AI Forecast
FCN Fti Consulting, Inc
- Price
- $195.99 +21.1% · 6M
- Market Cap
- $5.34B
- P/E Ratio
- 24.5x
- Size
- mid-cap
- AI Forecast
Which one does the AI model favor?
Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.
Six-month price performance
Closing prices rebased to 100 at the start of the window.
Key facts
- FCN is 2.8 times larger than ASTH by market capitalization ($5.34B against $1.92B).
- FCN trades at 24.5 times trailing earnings, ASTH at 48.6 times.
- Over the last six months FCN returned +21.1% and ASTH -4.4%.
- FCN turns 5.9% of its revenue into net income, against 1.4% for ASTH.
- ASTH carries 2.00 times debt per unit of equity, against 1.61 times for FCN.
- ASTH yields 0.59% in dividends; FCN pays none.
- Both companies share the SEC industry classification Services-Management Consulting Services.
Fundamentals side by side
Trailing twelve months.
Valuation & Market
| Metric | ASTH | FCN |
|---|---|---|
| Market Cap | $1.92B | $5.34B |
| P/E Ratio | 48.59x | 24.47x |
| P/B Ratio | 2.24x | 4.04x |
| Dividend Yield | 0.59% | – |
| EPS | $0.71 | $8.01 |
| Book Value/Share | $15.37 | $48.55 |
| Revenue/Share | $70.18 | $146.04 |
| FCF/Share | $1.78 | $12.98 |
Profitability & Margins
| Metric | ASTH | FCN |
|---|---|---|
| ROE | 6.2% | 17.6% |
| ROA | 2.3% | 6.8% |
| ROIC | 7.8% | 13.8% |
| Gross Margin | 10.9% | 32.2% |
| Operating Margin | 3.1% | 8.8% |
| Net Margin | 1.4% | 5.9% |
| EBT Margin | 2.2% | 7.9% |
| Tax Rate | 32.6% | 26.0% |
Financial Health
| Metric | ASTH | FCN |
|---|---|---|
| Current Ratio | 1.25x | 1.72x |
| D/E Ratio | 2.00x | 1.61x |
| Financial Leverage | 2.74x | 2.61x |
| Interest Coverage | 2.8x | 7.8x |
| Working Capital | $194M | $645M |
Cash Flow
| Metric | ASTH | FCN |
|---|---|---|
| Operating Cash Flow | $114M | $392M |
| Free Cash Flow | $99M | $354M |
| Capital Spending | -$15M | -$39M |
| OCF Growth YoY | 7.2% | 264.4% |
| FCF Growth YoY | 2.5% | 706.3% |
| FCF/Sales | 2.5% | 8.9% |
| CapEx/Sales | 0.4% | 1.0% |
Operational Efficiency
| Metric | ASTH | FCN |
|---|---|---|
| Asset Turnover | 1.67x | 1.15x |
| Receivables Turnover | 7.4x | 3.3x |
| Fixed Assets Turnover | 59.2x | 24.9x |
| Days Sales Outstanding | 50 days | 110 days |
| Payables Period | 5 days | 31 days |
Income Statement
| Metric | ASTH | FCN |
|---|---|---|
| Total Revenue | $3.91B | $3.98B |
| Operating Income | $121M | $352M |
| Net Income | $53M | $233M |
| SG&A Expense | – | $881M |
| Cost of Goods Sold | $3.48B | $2.70B |
Dividend & Shareholder Information
| Metric | ASTH | FCN |
|---|---|---|
| Dividends Per Share | $0.20 | – |
| Payout Ratio | 28.2% | – |
| Shares Outstanding | 56M | 27M |
| Net Income Growth | 457.1% | -12.3% |
| EPS Growth | 22.4% | 1.9% |
ASTH vs FCN: stock comparison and AI forecast
Which is bigger, ASTH or FCN?
FCN is 2.8 times larger than ASTH by market capitalization ($5.34B against $1.92B).
Which is cheaper on earnings, ASTH or FCN?
FCN trades at 24.5 times trailing earnings, ASTH at 48.6 times.
Which stock performed better over the last six months, ASTH or FCN?
Over the last six months FCN returned +21.1% and ASTH -4.4%.
Which one does Intratio's AI model rank higher, ASTH or FCN?
Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.
More comparisons
This analysis is generated automatically using our proprietary AI systems and should not be considered personalized investment advice. Past performance does not guarantee future results. Always conduct your own research and consider consulting a financial advisor before making investment decisions.